Exploring Cutting-Edge Therapies
NeuroSigma, Inc. is developing and commercializing neuromodulation treatments for a variety of disorders, including epilepsy, depression, post-traumatic stress disorder (PTSD), obesity, and cachexia. NeuroSigma employs two therapy platforms: Trigeminal Nerve Stimulation (TNS) and Deep Brain Stimulation (DBS).
CAUTION: The TNS and DBS therapies being developed by NeuroSigma are investigational therapies and limited by United States law for investigational use
To learn more about the Monarch™ eTNS™ System and its treatment of TNS please visit our specialty site.